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Abstract
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Adverse human health impacts due to occupational and environmental exposures to manufactured
nanoparticles are of concern and pose a potential threat to the continued industrial use and
integration of nanomaterials into commercial products. This chapter addresses the interrelationship between dose and response and will elucidate on how the dynamic chemical and
physical transformation and breakdown of the nanoparticles at the cellular and subcellular levels
can lead to the in vivo formation of new reaction products. The dose-response relationship is
complicated by the continuous physicochemical transformations in the nanoparticles induced by
the dynamics of the biological system, where dose, bio-processing, and response are related in a
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non-linear manner. Nanoscale alterations are monitored using high-resolution imaging combined
with in situ elemental analysis and emphasis is placed on the importance of the precision of
characterization. The result is an in-depth understanding of the starting particles, the particle
transformation in a biological environment, and the physiological response.
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4.1

Introduction
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Nanotechnology is a key modernization driver that balances innovations in material
synthesis with the need for novel solutions that impact all energy sectors, emerging medical
fields, and rapidly evolving electronics applications [3]. It also offers environmental
technology breakthroughs by integrating nanotechnology products and synthetic biology and
offers opportunities that focus on human health and animal welfare. The field of
nanomaterials is a multidisciplinary area in which material science is explored at the nanoscale, but the concepts behind nanoscience are not new. In his celebrated lecture at Caltech,
in 1959, physicist Richard Feynman described the process of manipulating and controlling
individual atoms, molecules and nanoparticles, and he anticipated an “enormous number of
technical applications” through the creation of novel materials and compounds [22, 76, 78].
More than half a century later, scientists and engineers are finding various ways to produce a
wide range of nanoparticles [1]. Importantly, the fast exploration and deployment of
nanomaterials must also incorporate exposure, toxicity and risk assessment studies in order
to balance the successful integration of nanomaterials into everyday life with any potential
safety and environmental issues [7, 17, 18, 48, 58, 69, 72, 78]. This is critically important in
determining which parts of life may be enriched with the assistance of nanomaterials and
which parts may suffer.

Author Manuscript

Manufactured nanoparticles (MNPs) typically range in size from 1–100 nm [23]. They
exhibit unique properties compared with those of their larger-sized “macro” counterparts.
The differences are due to vastly increased surface-to-bulk ratios and because of the distinct
structures of MNPs [13, 27, 80, 88]. Nanotechnology and the application of nanoparticles in
consumer products has become an integral part of today’s life and require safety assessments
[4, 12, 20, 27, 32, 34, 50, 59, 66, 73]. The growing rate of nanoparticle-based product
developments has raised worldwide apprehension regarding the release of MNPs into the
environment and their subsequent uptake. There are several uptake pathways for MNPs,
which complicates the issue of modelling exposure risks tremendously [5, 15, 30, 40, 54, 60,
83]. Nano-safety studies have seen an exponential rise over the past two decades, but the
effects and dangers of nanoparticles, either for animals, humans, or cell structures, are still
not clearly defined [10, 43]. Safety concerns have led industrial and academic researchers to
adopt strategies to make MNPs more biocompatible, by employing techniques such as
capping with various functional groups and also by exploring new synthesis routes [64], but
the ultimate fate of the MNPs after uptake remains unresolved [28, 56, 85]. This is, in part,
heightened by additional effects from nanoparticles that come from sources other than
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controlled manufacturing labs, such as pollution-derived nanoparticles where the
composition, size ranges and effects are often unknown. Another important issue is the
environmental significance of natural colloids and nanoparticles that govern elemental
mobility and bio-availability [33], where much of the environmental pool of nanoparticles
consists of breakdown products from both organic and inorganic sources such as cellulose
fragments and clays that may be in the same size range as MNPs. There is also the influx of
pollution-derived nanoparticles produced in urban settings from industrial effluents and auto
exhausts, which are an important part of risk assessment models and have been linked to
major health problems [11, 19, 88].

Author Manuscript
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Adverse human health effects due to occupational and also environmental exposures to
nanoparticles are of worldwide concern. Concepts of nanoparticle dose metric and response
metric are of paramount importance [42, 43] and can provide key insights into relationships
between the nanoparticles’ synthetic identity and chemical reactivity, their biological activity
which involves aggregation, protein interactions, protective surface coatings as well as
migration and, lastly, their stability, all of which contribute individually and collectively to
dose-dependent toxicity outcomes [79]. An in-depth understanding of biokinetics is vital to
obtaining meaningful risk assessment protocols for MNPs [71, 78, 87]. This has to include
information on the biodistribution and clearance of MNPs as a function of the exposure
route [43]. Furthermore, it has to include information on uptake, transport and
transformation of MNPs as a function of dose and epithelial route of entry (including but not
limited to gastro-intestinal, dermal and respiratory ports-of-entry). It also requires thorough
data collection on the biotransformation of MNPs within target tissues and cells [27]. The
cellular and subcellular interactions of nanoparticles are a function of the physiological
environment which can only respond to a certain number of invader nanoparticles or reactive
surface area (smaller nanoparticles contribute higher surface areas and in this regard, also
contribute different surface properties such as charge, composition, structures, porosity,
redox-state and reactivity). This is sometimes referred to as the “surface area dose-response
relationship” [61] and affects the short and long term fate of nanoparticles after uptake. Dose
and nanoparticle properties (nano-design) will undoubtedly influence the transport and
bioprocessing (in vivo effect) of the MNPs and their derivatives (break-down products)
which leads to a dose-dependent reactivity and physiological response (nanotoxicity) (Fig.
4.1).
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A dose-dependent instability of synthesized MNPs after exposure and cellular uptake leads
to in vivo processing and transformation, which may be followed by a certain response
(oxidative stress and inflammation) and ultimately results in nanotoxicity (Fig. 4.1). Clearly,
a nanoscale substance might potentially be toxic for a biological system when the “dose” or
concentration exceeds an adverse threshold. The response “effect” could be initiated by a
single “acute” dose, or, by repeated low “chronic” dose that occurs over an extended time
frame. Careful dose evaluations are necessary for meaningful risk assessments of
nanoparticles and play a major role in regulatory processes to help determine health-relevant
limits [43]. For example, instillation studies are typically carried out with high MNPs doses
and it is impossible to know whether effects are caused by overload conditions or due to the
MNPs’ inherent effects. Inhalation studies can offer insights at lower dose, yet they too are
met with inflammatory responses which have been determined more often than not to be
Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.
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independent of the nature of MNPs that are inhaled [43, 88]. Because of these difficulties in
dose-response studies, the mechanisms that induce toxicity from respiratory exposures are
poorly understood and thus hinder the building of predictive models. Similarly, low dose
response studies for MNP exposures to skin and gastrointestinal epithelial tissues are lacking
as is our understanding of how differences in the local biological milieu effects
microenvironment around a nanoparticle and vice-versa.
4.1.1

In Vivo Processing and Transformation of Nanoparticles
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The issue that will be addressed in this chapter is the relationship between dose and potential
in vivo processing of nanoparticles (response) shown in Fig. 4.1. The issue includes
nanoparticle uptake, transport and transformation as a function of dose and uptake routes. In
vivo processing is defined here as the dynamic chemical and/or physical breakdown of
nanoparticles at the cellular and subcellular level [27]. The process can be followed by in
vivo formation of new reaction products including ions, nuclei and growth of second
generation nanoparticles all of which may be set in motion by the breakdown of the original
nanomaterials. Such in vivo biotransformation processes are known to occur with implanted
orthopedic materials that can lead to both pathologic and beneficial patient outcomes. For
example, nanoparticle wear debris formed from articulating prosthetic surfaces can lead to
osteolysis [29], whereas the successful adherence and osteoinduction of amorphous
bioactive glass results from a dissolution and re-precipitation reaction and induces a material
phase change to crystalline hydroxyapatite [35, 39].
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Uptake and transport of nanoparticles to different regions in the body have been extensively
studied and are generally linked to certain pathology and toxicity [40, 43, 51, 52, 56, 61].
However, the in vivo breakdown and processing of MNPs that leads to formation of new
reaction products with different properties is not very clear and obfuscates the issue of
exposure risk and related outcomes. It also makes the design of meaningful predictive
models significantly more challenging. The breakdown mechanism of MNPs in cells
depends on the material composition, surface coatings, ports of entry and the organs they
invade (Fig. 4.2). The instability of nanoparticles in cells then initiates another cascade of
responses that yet have to be defined. In this Chapter, we describe applications of advanced
electron microscopy methods to the analysis of fixed tissue sections, which provides critical
information on material phase changes and the oxidation states of MNPs [27]. Specifically,
we discuss use of high resolution (nanometer) transmission electron microscopy (HRTEM)
coupled with simultaneous elemental analysis for the investigation of the in vivo processing
of nanoparticles as a function of dose and uptake route (Fig. 4.2). The in vivo processing
evidence can then be used for more comprehensive modelling of the potential exposure risks
for nanoparticles. The goal of these studies is to investigate cellular and subcellular
interactions of MNPs using advanced imaging and analysis of the retained particles and
correlate these interactions with biological and toxicological effects. The data are important
to build meaningful predictive models that are based on the dynamic interaction of
nanoparticles at the cellular and subcellular levels after uptake. A thorough understanding of
nanoparticle processing in biological systems as a function of dose is vital in making
determinations of the long-term toxicological effects. This requires studies to determine in
vivo solubility (nanoparticle dissolution), size and shape changes in response to the original
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dose and nanoparticle retention time (Fig. 4.2). A possible increase or decrease in protein
corona around the MNPs and their cell associations also must be examined [14, 25]. In vivo
processing of MNPs is a function of dose and residence time in particular tissues or cells.
The in vivo processed nanoparticles and any “newly” formed phases and reaction products
must be compared with the original MNPs (Fig. 4.2). The nanoparticle’s characteristic
“fingerprints” before and after in vivo processing are based on composition, geo metrical
parameters and physiochemical, structural and spectroscopic properties. Without this data, it
would be impossible to build meaningful models that correlate nanoparticle dose and
exposure risks. However, a deep understanding of biokinetics is also central to obtain an allencompassing exposure risk assessment and involves identification of target organs
following different routes of exposure. One has to evaluate the in vivo processing of MNPs
not only in the regions where uptake first occurs (portal-of-entry-organs), but also must
observe any particle breakdown or processing in secondary and further ancillary target
tissues while considering the original dose and residence time of the particles. Often the
experimental characterization of nanoparticles that is obtained before exposure is directly
linked to cellular-based assays. This means that risk assessment models typically assume
that the “invader” nanoparticles that cause toxicity are exactly the same as those that were
used in the exposure experiments. Unfortunately that is an oversimplification. To date we
know that nanoparticles are processed in vivo [28] and the extent to which they are
processed needs to be systematically studied so that this information can be incorporated
into advanced risk assessment models. Future studies will need to evaluate the in vivo
processing of MNPs in portal-of entry organs and also in secondary target tissues and
evaluate any modifications/transformations of MPNs with regards to their physicochemical
changes as a function of the route and duration of exposure. Only then can predictive models
be designed to better forecast nanoparticle-dose-toxicity relationships. State of the art
microscopy methods can be applied to obtain needed in vivo processing data, and several
examples of this approach are presented in the remainder of this Chapter.

Author Manuscript
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4.2

The Role of Cellular Breakdown and In Vivo Processing of

Nanoparticles
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The study of in vivo induced changes to nanoparticles is an emerging area of investigation.
In the case of highly soluble materials such as nano-copper and nano-silver any dissolution
and particle breakdown after uptake into biological media can be expected and has been
demonstrated [6]. However, the in vivo breakdown and transformation mechanisms of
essentially poorly soluble particles (PSP) like ceria (CeO2) on a cellular and subcellular
level are not well understood. The breakdown mechanism of CeO2 nanoparticles in the liver
of rats was recently demonstrated for the first time [27]. These findings confirm that
nanoparticle uptake and sequestration in peripheral organs can lead to the formation of
secondary particles with different physiochemical properties including altered reactivity and
effects that result in varying degrees of toxic effects over long periods of exposure.
Furthermore, ceria in vivo transformation can progress to a toxic, more benign, or
potentially beneficial state [32]. In this regard, CeO2 nanoparticles after prolonged residence
time of 90 days inside liver undergo in vivo processing that causes a shift towards smaller
particle size and an increased reactive surface area with enhanced free radical scavenging
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potential of the new in vivo formed ultrafine particles [27]. This work also showed with the
help of high resolution imaging and analysis that essentially insoluble CeO2 nanoparticles
experience partial dissolution and reformation inside the liver. Breakdown and redistribution
after inhalation of ceria nanoparticles could be a possible coping mechanism of biological
systems and a step towards improving nanoparticle biocompatibility as illustrated in Fig. 4.3.
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Because CeO2 is basically insoluble under laboratory controlled conditions, one has to
question what drives dissolution of CeO2 and similar nanoparticles in the liver, lung and
possibly other regions in vivo and whether enzyme activity and other factors need to be
incorporated into risk assessment models. This is particularly important for more soluble
nanoparticles such as amorphous silica (SiO2), alumina (Al2O3), titania (TiO2) and iron
oxides (Fe2O3 and Fe3O4) which constitute the vast volumes of MNPs used today in
consumer products and medical imaging. Faster dissolution rates could lead to rapid particle
breakdown and transformation. Clearly, how to obtain insights into biotransformation routes
of nanoparticles and their in vivo processing response depends on well-designed
experimental studies that provide dose-controlled nanoparticle uptake, i.e., via instillation,
inhalation (lung, olfactory system), oral intake (stomach, GI) or dermal uptake (skin: intact
versus injured) (Fig. 4.2). This has to be followed by a systematic comparison of the in vivo
transformed particles with the pristine precursor materials by examining morphological
changes, size variations, dissolution patterns and the presence or absence of secondary
reaction zones (new precipitates) in the vicinity of the transforming nanoparticles. Further
detailing the physio-chemical changes during bioprocessing of nanoparticles may be an
effective tool in understanding their subcellular and temporal fate that controls toxicity.
These analyses depend on advanced imaging methods. High-resolution electron microscopy
applications allow the use of fixed tissues to examine nanoparticle location, size and
composition immediately after deposition and also after prolonged residence time.
Nanoparticle-cell interaction and dose-dependent inflammatory response raises the question
about underlying cellular mechanisms that produce nanoparticle instability (Fig. 4.2).
Therefore, dose-dependent toxicity that is caused by in vivo processing of nanoparticles
needs to be considered in risk assessment models. Also, it is important to model
nanotoxicity as a function of the nanoparticle instability, transformation, mobility and
potential in vivo reformation (precipitation) at the cellular and subcellular level.
Nanoparticle instability in vivo is a function of the particle’s inherent composition, size,
molecular structure and surface chemistry among other properties, but also a function of the
complex cellular condition such as protein corona, inflammatory responses (chronic vs.
acute), upregulation of inflammatory defense mechanisms and availability of enzymatic
catalysts just to name some. Mobility of individual nanoparticles may be controlled by both
physical transport of the intact particles, and also by a sequence of dissolution and
reformation steps. High resolution analysis of the reaction zones around dissolving
nanoparticles in phagolysosomes show breakdown patterns, void spaces and pore-formation,
suggesting that there are continuous processes that release and relocate molecules during the
nanoparticle transformation. This information is important in creating government
regulations for nanoparticle exposure to workers and consumers. One very important aspect
for obtaining nanoscale structural and chemical information to be able to study the
breakdown and processing of MNPs, of course, is the preparation and conditioning of tissue
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materials which precedes all of the advanced imaging and analysis techniques. We refer here
to previous works that give excellent overviews of the tissue preparation techniques [49, 55,
74].
The following sections will discuss the importance and application of advanced imaging
methods to help identify the various processes involved during in vivo nanoparticle
transformation and give three specific examples for: (1) high and low dose inhaled
amorphous silica (SiO2) nanoparticles that are deposited, transformed and relocated inside
rat lung; (2) ceria (CeO2) nanoparticle dispersion and in vivo processing in spleen after a
single high dose instillation; and (3) discuss the spatial and temporal relationship of in vivo
synthesized ferritin nanoparticles (iron oxy-hydroxide Fe-OOH) as a direct response to the
uptake and processing of invader SiO2 and CeO2 nanoparticles, and suggest mechanisms at
the cellular and subcellular levels.

Author Manuscript

4.3

Advanced Imaging and Analysis of Nanoparticles in Tissue Sections
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The study of nanoparticle in vivo processing is compounded by the number of variables in
play when it comes to biotransformation, such as composition, morphology, size, and
exposure mechanism or route of entry. The situation is made even more complex for
researchers in that specialized methods of investigation are required to observe nanoparticle
transformations in biological systems. Typical methods employed in biological research can
only partly reveal nanoparticle transformations or information about the mechanisms
involved due to the small size range. These methods include fluorescence, confocal, and
polarized microscopy, electron micro-graphs, radiological tracing, and measurements of
biological toxic response indicators. Traditional material characterization methods used by
material engineers/scientists need to be employed that allow resolution and analysis at the
nanoscale. Methods that have been employed so far are the standard electron microscopy
techniques used in materials characterization such as, electron diffraction [2, 27, 46], and
scanning transmission electron microscopy (STEM) [81] with the associated analytical
techniques energy dispersion spectroscopy (EDS) [36, 84], and electron energy loss
spectroscopy (EELS) [16, 26, 80]. Also, x-ray photoelectron spectroscopy (XPS) has been
used [27]. Aberration corrected STEM allows imaging at the atomic scale and will be
instrumental in determining the structures and composition of in vivo formed nanoparticles
that are only a few nanometers or possibly sub-nano size [57]. The use of these methods is
complicated by the nanoparticles being hosted inside a biological matrix. This requires
modifications to the standard biological sample preparation techniques [49, 55, 74].
4.3.1

High Resolution Analytical Microscopy

Author Manuscript

Electron microscopy has been fundamental in gaining knowledge about biological systems
since the 1950’s and was instrumental in developing insights into cellular ultrastructure [21].
As electron microscopes evolved, the imaging needs of the biologist and that of material
scientist diverged. The biologist needed high contrast, wide field, and low accelerating
voltages, whereas the material scientist needed high resolution imaging, high accelerating
voltages, and high brightness through the use of a field emission electron source. This
resulted in differing classes of electron microscopes being manufactured such as the Philips
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201 and CM-10 for biological applications versus the Philips 300, 400, and CM-12 for
material characterization. This has resulted in major medical research centers having
biologically oriented electron microscopes with an inability to apply what are now common
material characterization techniques. Multidisciplinary collaborations between medical
researchers and material scientists can overcome this. High-resolution transmission electron
microscopy (HRTEM), coupled with advanced detectors allows one to probe materials in
unprecedented detail, providing both local chemical information and also structural
properties.
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An analytical electron microscope today can image and obtain compositional and electronic
information down to the angstrom level. This ability provides highly local information from
surface-environment interactions such as in vivo nanoparticles. Other material
characterization techniques work for bulk samples and have resolutions larger than several
nanometers. Thus, for the study of in vivo transformation of nanoparticles there is only one
choice, an HRTEM designed for materials analysis [28, 84]. A typical HRTEM used in
materials characterization will have both TEM and STEM capability with EDS and EELS
being incorporated with the use of computer technology to allow the acquisition of
elemental line profiles and maps acquired in STEM mode. This allows not only elemental
analysis but also acquisition of material phase changes and oxidative states via the EELS
data [16, 53]. Combining these observations with material phase databases such as the
Materials Project (www.materialsproject.org) and computation from first principles using
spectroscopy oriented software such as FEFF9 [67] in principle, allows the identification of
phases and electronic states. Because a standard non-aberration corrected field emission
electron microscope designed for materials analysis will typically be able to achieve a
STEM spot size of 0.2 nm, changes in nanoparticle surfaces versus their main bodies can be
analyzed [27]. This data combined with material phase structure data and spectroscopy
computation can, in principle, provide information on structural and electronic changes in
nanoparticles in tissue. This is the type of information needed to understand the interaction
of a nanoparticle with its local environment in order to gain an understanding of the
mechanisms behind in vivo transformation and how this relates to toxicity.
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4.3.2

Example I: Amorphous Silica (SiO2) Inside Lung Tissue
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Analysis of the clearance kinetics using modelling of retained lung burden of SiO2-MNPs
showed a significant in vivo solubility which raises questions about underlying cellular
mechanisms that result in the instability of the SiO2-MNPs and related toxicity [24]. This
was the stimulus to use HRTEM applications and to look for evidence of particle breakdown
and mobility in the lung tissue at both cellular and subcellular levels. The principal objective
for HRTEM is to examine any nano-scale alteration, dissolution and processing of SiO2MNPs after inhalation by comparing the translocated particles with the precursor SiO2MNPs. A dose and time controlled inhalation study involved groups of rats that were
exposed to aerosols containing amorphous SiO2-MNPs for 4 h/day, 5 days/week for 4 weeks
with a 27 day post-exposure observation period at three different concentrations and dosedependent pulmonary inflammation in the rats, and data was collected in relation to the
exposure time and corresponding dose that was used [62]. In this particular study, subchronic inhalation exposures of the SiO2-MNPs were investigated using an approach of
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dosimetric modelling to determine the mechanisms for clearance of these nanoparticles from
the lung. Both mechanical clearance and partial dissolution have to be considered as
potential pathways. Determining the in vivo bioprocessing mechanisms of the nanoparticles
will be important towards risk characterization and to better assess possible health effects
caused by the transformation, translocation and clearance of the particles after exposure. The
HRTEM observation of the precursor (as synthesized) SiO2-MNPs particles showed a
typical size of ~20–50 nm with a corresponding spherical morphology of the individual
aerosolized SiO2-MNPs components (Fig. 4.4). Furthermore, after 27 days post-exposure
the phagocytosed SiO2-MNPs that were sequestered in alveolar macrophages in the fixed
tissue sections were imaged using high resolution Dark Field STEM. The STEM images
show clear indication of significant in vivo breakdown and transformation (Fig. 4.5). There
is also structural evidence in the Dark Field STEM (Fig. 4.5) that a portion of SiO2-MNPs
had been completely dissolved out. The degree of in vivo processing of the particles and
partial dissolution most likely depends on the residence time, dose, and synthetic identity of
the original inhaled SiO2-MNPs. Most of the SiO2-MNPs particles lost their original
spherical morphology after prolonged lung retention and are now displaying various
dissolution patterns (pitting), void formation and secondary outward growth that results in
the formation of multiple reaction zones. To gain greater insights into what controls particle
transformation and determine if there are any relationships with subcellular components, one
has to perform detailed elemental mapping of the regions of interest. As an example,
elemental EDS maps of O, Si, S and P (Fig. 4.6) are obtained from a region that is illustrated
in the Dark Field STEM image in Fig. 4.5. The EDS elemental maps of O, Si, S, and P
require the use of a 1 nm STEM probe to have enough counting statistics within a reasonable
dwell time as illustrated in (Fig. 4.6).
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Typically a 1–2 s dwell time is used depending on the signal strength. EELS mapping can be
done with a 0.2 nm probe and dwell times as small as 0.1 second, depending on the
elemental edge being mapped. Higher edges require longer dwell times. When doing
simultaneous EDS and EELS mapping a compromise must be worked out to have a long
enough time for a good EDS count and short enough so as not to overload the EELS CCD
detector [27]. Other EELS acquisition parameters such as dispersion and y-binning can be
adjusted to obtain a satisfactory EELS signal [16, 26]. After performing EDS mapping of a
region that seems to have undergone in vivo processing of SiO2-MNPs in alveolar
macrophages the O and Si signals clearly follow the outline of the SiO2-MNPs (Fig. 4.6).
However, the Si signal furthermore is indicating that some Si is present in the close
neighborhood of the SiO2-MNPs, while the O signal is predominantly confined to the
outline of the alveolar macrophage-entrapped nanoparticles and not seen in the immediate
subcellular surroundings. Some O may be present in –(Si-O-Si)- forming anionic silanol
components within the tissue and this could be a critical mechanism for Si transport and new
precipitates and studies are needed at the molecular level to determine the processes
involved in Si mobility after processing of the MNPs. The elemental scans for S and P were
included here to show that, surprisingly, the signals are shadowing the location of the SiO2MNPs. This opens chief questions for future work including queries into the underlying in
vivo processing mechanisms that guide nanoparticle delivery to certain cellular and
subcellular locations and chemical environments after uptake and also how this may be
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affected by dose. The dose variations (high vs. low) all resulted in significant in vivo
processing of the SiO2-MNPs after inhalation which probably is based on the relatively high
solubility of amorphous silica [9, 24, 31]. Importantly, in vivo processing gives rise to
second generation nanoparticles and reaction zones containing Si- phase within the vicinity
of the bio-transformed SiO2-MNPs, which suggests that migration and relocation processes
take place at the cellular and subcellular levels as determined in elemental mapping (Fig.
4.6). Moreover, high resolution STEM coupled with EDS confirms that release of Si ions
and relocation and precipitation of secondary Si- phases in the alveolar macrophages results
in generation of Si-rich halos “Si-clouds” at the outskirts of partially dissolving SiO2-MNPs
(Fig. 4.7). An analogous cloud-formation process was shown for the first time to take place
when poorly soluble ceria (CeO2) nanoparticles bio-process in liver tissue [27].
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Detailing all of the physio-chemical changes that take place during bioprocessing of SiO2MNPs in alveolar macrophages and other tissue locations as a function of dose is still under
development. This may be an effective tool in understanding their subcellular and temporal
fate and how this factors into controlling a toxic response after environmental uptake of
nanoparticles. More work is needed to study the dose effects on the extent of SiO2-MNPs
breakdown and the relocation of Si as a function of saturation levels. An example of further
detailing the chemical and structural content of the Si-Cloud contents is shown in the Dark
Field STEM images that demonstrate a greater extent of in vivo processed SiO2-MNPs in
the alveolar macrophage and the development of nanozone formation (Fig. 4.8). The
chemical breakdown of the SiO2-MNPs (Zone I) leads to pitting in the original particles
with subsequent material migration and relocation into satellite zones (Zone II in Fig. 4.8)
which hosts much smaller particles that are highly dispersed. This is the reason why Zone II
appears less dense and concentrated in the Dark Field STEM image. It will be of paramount
importance to apply aberration corrected STEM and 3D– imaging to probe the chemical
composition of the matrix of Zone II that engulfs the very small SiO2-MNPs. If Zone II
matrix is chemically distinct from other nanoparticle- free regions in the alveolar
macrophage that hosts the SiO2-MNPs it can help determine if protein formation or
encapsulation helps stabilize the SiO2-MNPs and make them more biocompatible after in
vivo processing.
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The examples above show that in vivo processing of nanoparticles can occur and that a
materials-oriented electron microscope can reveal some aspects of the changes that are
occurring. This coupled with toxicological response monitoring could provide information
as to whether nanoparticle dose-dependent changes reduce or increase toxic effects. Much
work remains to be done in determining the in vivo properties of the many different types of
nanoparticles and how variables such as particle morphology, size, surface treatments, and
composition effect in vivo processing. The application of aberration corrected electron
microscopes to the study of in vivo processing would most likely be very fruitful [65, 86].
These microscopes have the resolution to determine if a cloud surrounding a nanoparticle is
composed of single molecules or very small clusters as in the silica examples above. It could
also determine if the composition of such clusters is that of the precursor particle or if a
reaction has occurred thereby modifying the clusters and resulted in new compounds. In
addition aberration-corrected STEM could provide high resolution maps of the surface
layers of nanoparticles and corresponding surrounding tissue to better understand the
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mechanisms behind in vivo processing. Importantly, aberration-corrected electron optical
sectioning can give insights into any potential protein corona formation at the exterior of the
nanoparticles. Recently, RAMAN mapping has also become commercially available. This
opens the possibility of identifying molecular changes in the tissue surrounding
nanoparticles in vivo as a function of dose.
4.3.3

Example II: Ceria (CeO2) Nanoparticles Inside Spleen Tissue
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EELS analysis was performed on a 200 kV JEOL 2100F TEM/STEM and spectrum images
were collected to investigate morphologies, size distribution and oxidation states of ceria
nanoparticles (CeO2-MNPs) in rat spleen tissue. A therapeutic dose (4 g/kg) of ~15–20 nm
CeO2-MNPs was used and instilled four times over a 2 week time period. The hydrothermal
synthesis procedure for the CeO2-MNPs resulted in a narrow size range ~20 nm [47]. The
particle surfaces were capped using a citrate coating (10 %) in 5 % aqueous dispersion. The
(CeO2-MNPs) synthetic identity included size, surface charge (Zeta potential: −40 mV at pH
7.3) and structural characterization using HRTEM/STEM analyses and EELS in the spleen
tissue (Fig. 4.9).
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Previously, the in vivo processing, transformation and subcellular effects of CeO2-MNPs in
a rat model using a single high dose (85 mg/kg) was presented with corresponding effects on
oxidative stress increases and decreases and internalized CeO2-MNPs were shown to cause
distinct cellular responses and oxidative stress, but also presented significant in vivo
processing which releases smaller CeO2-MNPs clouds with much improved ROS potential
[27, 32]. Since CeO2-MNPs can do both generate and scavenge free radical oxygen species
(ROS), it is important to distinguish CeO2-MNPs that contribute to either ROS production or
ROS scavenging in subcellular levels [41]. Example II shows how ceria MNPs translocate to
spleen tissue and in the spleen the original CeO2-MNPs produced Ce-clouds (Fig. 4.9). In
this particular case a therapeutic dose (4 g/kg) of CeO2-MNPs not only bio- accumulated in
spleen which can be demonstrated with the help of HRTEM and Dark Field STEM imaging,
but the original ceria nanoparticles were also structurally altered and second generation
plumes of ultra-fine (<3 nm) ceria nanoparticles formed close by, which can be seen as
clouds next to the in vivo processed ceria precursors (Fig. 4.9). Corresponding EELS
analyses along the EELS-trace line in Fig. 4.9 compare the redox state of the precursor and
newly precipitated ceria clouds. The high angle STEM analysis along the EELS line profile
used a small probe size (0.2 nm) to minimize any fixed tissue sample damage that could
occur under the prolonged electron beam exposure. The oxidation states of Ce were
determined by the fine structures of M4,5 edges in EELS as described elsewhere in details
[77]. The schematic in Fig. 4.10 gives some insights on how to compute the EELS edges for
Ce and, in particular, the energy loss for Ce M4 versus Ce M5. The greater the contribution
of Ce M5, the higher is the ceria reduction potential [77]. Interestingly, the same kind of Cecloud formation was also shown previously for a high-dose of CeO2-MNPs after intravenous
uptake and sequestration of CeO2-MNPs in liver and was associated with a much improved
ROS potential [27]. Different valance states of the ultra-small CeO2-MNPs needles are
characterized by core loss EELS to have very high Ce+3 signatures (corresponding to
oxygen vacancies) as evidenced by the greater Ce M5 contributions obtained via the EELS
analyses and are similar to those in the Ce-clouds (Fig. 4.9). Both HRTEM and Dark Field
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STEM demonstrate that Ce-phosphates formed in the spleen and this typically occurs in
lysosomal regions where ultra-small ceria particles transform/reform (the mechanism of
transformation/reformation is not known at this time) (Figs. 4.11 and 4.12).
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Elemental maps can be produced from EDS and EELS spectrum images (in high resolution
STEM mode) and in the example below span across the regions where the Ce-nanoparticles
accumulate. This information can then be used to build a thorough understanding of the
temporal, structural and cellular relationships involving tissue composition and location of
nanoparticles. An example is shown in Fig. 4.13 where elemental maps were generated over
a select region that is illustrated using dark field STEM in 4.12. These are fairly low EELS
pixel count maps in order not to destroy the tissue structures during the prolonged electron
beam scanning. Therefore, a low angle dark field STEM condition has to be selected to bring
out the cellular structures in the spleen (Fig. 4.13) while simultaneously analyzing the
relative elemental composition and spectral signatures of for example Ce, P, C, Ca, N and O
in the same region using STEM spectrum imaging (Fig. 4.13).
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Elemental maps obtained from the EDS and EELS spectrum images allow for a comparison
of the elemental distribution that is associated with the cellular structures and that of the
accumulated nanoparticles. The low pixel count maps take about 30 min to acquire. Higher
pixel count maps can be obtained but the required time increases rapidly and this can affect
the beam/sample interaction and lead to artifacts. Elemental imaging may also be
accomplished using an EELS imaging filter. Typically an in-column filter is more successful
on biological specimens due to the smaller beam dose required. When using post column
filters the sample stability may be impacted due to the high brightness required (electron
intensity). The elemental imaging for Ce-MNPs that seem to preferentially locate around
globular lipid-based components (Figs. 4.12 and 4.13) clearly shows that the Ca and N are
highly enriched as part of the internal composition of the lipid structures and they have an
outer shell or corona that is phosphor rich (P signal is high at the outside of the globular
structures in Fig. 4.13). The Ce signal completely overlaps with the P signal suggesting, at
the least, a spatial relationship. In case of the preferential Ce deposition at the outside of the
lipid structures it would suggest that there is either a mechanism that controls the delivery of
the Ce-MNPs to that particular P-rich location or, that Ce ions migrated to that region and
formed new Ce-oxides, Ce-hydroxides or Ce-phosphates. The O-signal clearly shadows the
areas of both, Ce and P signals (Fig. 4.13). The elemental map of the S-signal shows that it
is confined to the lipid structures only. At this time it is not known how certain regions in
cells govern nanoparticle delivery and accumulation, but there seems to be an underlying
chemical control that needs to be considered. Much work will be required to understand the
relationship between tissue components and nanoparticles, but the use of HRTEM/STEM
and EELS is certainly a tool that will be very useful towards that goal. How the MNPs’ portof-entry, dose, exposure duration and post-exposure time factor into the transport
phenomena, particle transformation and in vivo processing mechanisms is not known at this
time.
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The uptake and sequestration of MNPs, both silica (amorphous SiO2) and ceria (CeO2)
results in the partial breakdown and in vivo processing of the original MNP-particles as
discussed in Examples I and II in earlier sections in this Chapter. Remarkably, there is
additional evidence one can gain from HRTEM: the presence of different MNPs (SiO2,
CeO2) in different organs (lung, liver, spleen) after being delivered via different uptake
routes (inhalation, intravenous), have at least one response in common, specifically, the
simultaneous formation of ferritin nanoparticles in the vicinity of the invader MNPs.
Ferritins represent bio-mineralized iron nanoparticles that are typically 5–8 nm in size and
trapped inside the cage of the iron storage protein [8]. They occur immediately juxtaposed to
the cell-invading and inflammation-inducing MNPs [27]. Moreover, the ferritin
nanoparticles are highly concentrated next to the MNPs when compared to tissue regions
that are not affected by inflammation, as shown in the Dark Field STEM images in Figs.
4.14 and 4.15. The individual solitary bright white spots surrounding the invader MNPs
(inside the lysosomal regions) each represent one ferritin nanoparticle of 5–8 nm size (Figs.
4.14 and 4.15). It is well established that ferritin nanoparticles form during the biomineralization of ferrous (reduced) iron. A conserved iron-binding site, the ferroxidase
center of the ferritin protein regulates iron storage in iron metabolism [38]. It is generally
assumed that ferrous iron Fe(II) binds the ferroxidase center and the oxidized iron Fe(III)
spontaneously enters the ferritin cage. High resolution imaging as well as spectroscopic and
kinetic studies of ferritins (family of 24 iron storage proteins), suggest many common
characteristics, including highly symmetric subunits of a cavity-engulfing protein coating in
which the iron bio-mineralization takes place. Furthermore, there are four channel passages
through the protein shell that help facilitate ingress and egress of ions which results in an
iron core with eight subunits rather than a single dense sphere [75]. There are catalytic sites
at the inner shell “ferroxidase center” which control the oxidation of Fe(II). The mechanisms
of biomineralization of iron that result in ferritin nanoparticles like the ones shown in Figs.
4.14 and 4.15 are described elsewhere [8, 38], but the association (close locality) with
invader MNPs is novel and requires a thorough investigation of the subcellular mechanisms
and participation of iron as a redox mediator to counter the effects of invader MNPs. The
significance of iron in biological systems is due to its ability to engage in redox reactions,
including the scavenging of free radicals [27]. In general, iron forms a labile iron pool that
includes iron atoms, but free Fe(II) must be managed either by use in hemoglobin or inside
of the iron storage protein, ferritin. Otherwise, reduced Fe(II) iron can participate in the
Fenton reaction and cause free radical formation [44]. There are numerous transferrin
receptors, all of which are proteins that participate in iron transport at the cellular and
subcellular levels. Once Fe(II) is sequestered in the ferric form within the ferritin protein
shell, this particular iron will not participate in free radical formation. In fact, the oxidation
of one Fe(II) to Fe(III) releases an electron that can neutralize a free radical species and,
thereby, act as an anti-oxidant. Each ferritin cavity can hold up to 4500 oxidized iron atoms
[63] and each one had to release an electron while being oxidize. It is this catalytic process
that provides ferritin with the anti-oxidant property. The physical characterization of the
ferritin particles includes details of the protein shell as well as characterization of the
mineralized iron oxide core. In the high resolution dark field images of the lung and spleen
thin sections only the iron oxide core is visible due to the comparatively high atomic number
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and close packing of the iron atoms, while the surrounding ferritin-protein shell has about
the same density and general chemical make up as the cellular matrix and, therefore, is
difficult to distinguish (Figs. 4.14 and 4.15). The dense iron core allows z-contrast imaging
using HAADF-STEM (Figs. 4.14 and 4.15). When using aberration corrected STEM this
technique provides insights into the detailed morphologies and structures of the iron core
[70]. Although the exact composition and stoichiometry of the core is not well understood
yet, most literature today suggests that the core is composed of a ferrihydrite (ironoxyhydrite) and also approximates this structure in human liver [63].
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The copious ferritin nanoparticles that form halos around sequestered MNPs (Figs. 4.14 and
4.15) occur in such a high concentration that it, unmistakably, seems to be a direct response
to the presence (invasion) of the MNPs in either the lung or spleen (Figs. 4.14 and 4.15).
Ferritin nanoparticles are typically present throughout cells, but not in the particularly high
concentration that is shown inside the ferritin-halos around MNPs (Figs. 4.14 and 4.15).
Unexpectedly, the elevated ferritin nanoparticle accumulation seems independent of the
nature of the MNPs (amorphous SiO2, CeO2 and others not shown in this Chapter). The
mechanisms that control the abundant in vivo formation of ferritin nanoparticles next to the
invader MNPs need to be further investigated, but it seems to indicate that the cellular and
subcellular response mechanism(s) trigger an upregulation of iron immediately juxtaposed
to the MNPs. This is very important since MNPs are linked to inflammatory processes and
possible cell toxicity, which results in formation of free radicals [44]. Either the MNPs or the
free radicals, or both, initiate mechanisms that trigger the upregulation of iron in the same
regions. Consequently, ferritin nanoparticles that form as a result of the oxidation of Fe(II) to
Fe(III) can participate in free radical scavenging processes as mentioned earlier and provide
the needed anti-oxidant response to counteract invader MNPs. This can explain the ferritinrich halos that are observed in the HAADF-STEM images around the MNPs (Figs. 4.14 and
4.15). At this time there is no available data on a nanoparticle induced dose-dependent
ferritin response, but it seems logical that the higher the MNPs dose, the greater the ferritin
nanoparticle concentrations would be in the affected tissue regions.
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4.4

Synchrotron Analysis: Dose-Dependent Nanoparticle Signatures in

Tissue
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X-ray absorption spectroscopy methods making use of synchrotron radiation, such as
XANES and EXAFS, may prove useful in providing information on the electronic and local
atomic structure of elements in nanotoxicology. A screening of selected tissue samples for
elements of interest may provide information regarding the incorporation of such elements
from exposure to nanoparticles as a function of a particular dose that led to a certain
pathological response. An important analogy is when an X-ray absorption spectroscopy
survey was conducted on coal samples to determine the chemical nature and structure of
elemental impurities. In that case, the researchers were faced with a similar staggering
problem. Coal contains nearly the entire periodic table as impurity elements, and many of
the impurity elements were of concentrations 1000 ppm or less, which could not be
confidently characterized by conventional microscopic, spectroscopic, or diffraction
techniques [82]. Using predominantly fluorescence mode, significant and important
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information was obtained on numerous trace elemental impurities in coal using X-ray
absorption spectroscopy [37]. Just below the edge energy and prior to the single scattering
region, pre-edge features provide useful information on site symmetry (e.g., a sharp feature
is typically produced with tetragonal symmetry, while octahedral generally produces a faint
signal), the white line region provides information on the oxidation state of the material, and
the multi-scattering region provides information on the immediate environment of
neighboring atoms. The higher energy region provides a wealth of information on the
identity of neighboring atoms, their interatomic distances, and their degree of coordination.
Although XANES in principal can also be obtained in high resolution STEM mode using
electron microscope applications, elemental dispersion over larger tissue areas is not
possible using large magnification settings and needs to be done at a synchrotron source.
Two examples related to catalyst particles (iron oxide and ceria nanoparticles) that are often
examined with regards to their nano-toxic response are provided below. In the first case [68]
the role of the element K in promoting the carburization rate of iron oxide in FischerTropsch synthesis catalysts was explored by XANES and EXAFS spectroscopy. The
XANES spectra were recorded with the catalyst heated in flowing carbon monoxide (Fig.
4.16a). Changes in the white line are evident (Fig. 4.16a), and in comparing the spectra to
those of reference compounds, reduction was found to proceed by way of Fe2O3 to Fe3O4 to
FeO to Fe carbides. Simultaneous EXAFS spectra were recorded (Fig. 4.16b). The low
distance- peak of Fe-O coordination and the high distance peak of Fe-Fe coordination in
Fe2O3 change to match the distances of Fe-O and Fe-Fe coordination in Fe3O4. At the end
of the trajectory, Fe-C bonds in Fe carbides are clearly observed in the intermediary range of
distance. Thus, the two techniques (XANES and EXAFS) provided similar information on
the chemical changes occurring, but simultaneously and from two different perspectives.
Bio- mineralized iron oxides are very often present at the cellular and subcellular levels and
it is important to distinguish oxidation states and also to observe whether iron may be
coordinated to carbon, sulfur or phosphor and if variations occur as a function of dose
(nanoparticle exposure).
A second example [45], on the doping of nanosized ceria (CeO2) domains with platinum
doping of 0.5 % (by weight) and 50 % (by mole) calcia, is described below. The XANES
patterns of Ce4+ and Ce3+ are very different (Fig. 4.17a).
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where Ce4+ contains two very broad peaks, as well as additional features, while Ce3+
exhibits a sharp distinct peak, B0. This is based on changes in the electronic structure of
ceria, and its effect on the allowed electronic transitions. When the same CeO2 nanoparticle
catalyst was heated in hydrogen (Fig. 4.17b) to activate the surface by reduction, the
addition of the dopants (Pt and Ca) facilitated surface shell reduction to ~200°C (from 450
to 500°C for undoped ceria), and bulk reduction commenced at ~400°C (rather than >700°C
for undoped ceria). This clearly demonstrates the sensitivity of the analysis tool towards
elemental, structural and thermal changes as a function of reduction potential. Thus, using
high intensity X-rays generated at the synchrotron can provide a wealth of information
regarding the identity, chemical state, and local atomic structure of nanoparticles, and may
provide key information in any survey of tissue samples for nanotoxicology.
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In this chapter the inter-relationship between dose, nanoparticle uptake, cellular and
subcellular interactions and nanotoxicity has been discussed with examples of means of
observation of in vivo bio-processing and response. Emphasis is placed on the importance of
the precision of characterization of the starting particles, the particles in a biological
environment, and the physiological response. The relationship between dose, bio-processing,
and response is an area of active research as all three may be related in a non-linear manner.
It is pointed out that relatively insoluble materials like CeO2 have been observed in vivo to
undergo significant changes in shape, size, material phase and electronic structure. Because
of this, the modelling and prediction of dose versus toxicity over time becomes a non-linear
problem because the initial particles can transform over time and initiate different responses
that evolve as the dynamic system undergoes further transformations. The examples in this
chapter illustrate two advanced materials characterization methods that are useful in the
characterization of nanoparticles, before and after introduction in the biological
environment, and in observing specific types of physiological response. These methods are
advanced analytical electron microscopy (STEM/EELS) and x-ray absorption near edge
spectroscopy (XANES). In conclusion the dose response relationship is complicated by the
physicochemical transformations in the nanoparticles induced by the biological system
producing an altered response. Thus, the modelling and prediction of dose-response-toxicity
relationships has to take into account non-linear dependencies when attempting to predict a
dose versus toxicity response relationship. This has to be especially considered when
predictive modelling of nanomaterials utilizes in vitro models. Therefore, the long-term goal
is to develop cellular in vitro models that can support dynamic processing of nanoparticles
for exposure risk assessment.

Author Manuscript

References

Author Manuscript

1. Altavilla C, Ciliberto E (eds) (2010) Inorganic Nanoparticles Synthesis, Applications, and
Perspectives. CRC Press, Boca Raton, Florida, p 576 Print ISBN: 978–1-4398-1761-2, eBook
ISBN: 978-1-4398-1762-9
2. Anderson SC, Birkeland CR, Anstis GR, Cockayne DJH (1997) An approach to quantitative
compositional profiling at near atomic resolution using high-angle anular dark-field imaging.
Ultramicroscopy 69:83–103
3. Bates ME, Keisler JM, Zussblatt NP, Plourde KJ, Wender BA, Linkov I (2015) Balancing research
and funding using value of information and portfolio tools for nanomaterial risk classification. Nat
Nanotechnol 9:249
4. Baisch BL, Corson NM, Wade-Mercer P, Gelein R, Kennell AJ, Oberdörster G, Elder A (2014)
Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body
inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol 11(5):
16 PMCID:PMC3905288 [PubMed: 24708749]
5. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI (2004)
Pulmonary responses of rats, mice, and hamsters to subchronic inhalation of ultrafine titanium
dioxide particles. Toxicol Sci 77:347–357 [PubMed: 14600271]
6. Bilberg K, Hovgaard MB, Besenbacher F, Baatrup E (2012) In vivo toxicity of silver nanoparticles
and silver ions in zebrafish (Danio rerio). J Toxicol 2012:9 Article ID 283784
7. Bonner JC, Silva RM, Taylor AJ, Brown JM, Hilderbrand SC, Castranova V, Porter D, Elder A,
Oberdörster G, Harkema J, Bramble L, Kavanagh TJ, Botta D, Nel A, Pinkerton KE (2013)

Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 17

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials. Environ
Health Perspect 121:676–682 PMC3672912 [PubMed: 23649427]
8. Bradley JM, Moore GR, LeBrun NE (2014) Mechanisms of iron mineralizaiton in ferritins: one size
does not fit all. J Biol Inorg Chem 19(6):775–785. doi:10.1007/s00775-014-1136-3 [PubMed:
24748222]
9. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ (2006) In
vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle
solubility. Environ Sci Technol 15(4D(14)):4374–4381
10. Burello E, Worth AP (2011) A theoretical framework for predicting the oxidative stress potential of
oxide nanoparticles. Nanotoxicol 5(2):228–235
11. Buzea C, Blandino IIP, Robbie K (2007) Nanomaterials and nanoparticles: sources and toxicity.
Biointerphases 2(4):MR17–MR172 [PubMed: 20419892]
12. Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, Larese FF (2009) Nanoparticle
dermal absorption and toxicity: a review of the literature. Int Arch Occup Environ Health 82(9):
1043–1055 [PubMed: 19705142]
13. DeSouza PM, Neto RCR, Borges LEP, Jacobs G, Davis BH, Graham UM, Resasco D, Noronha FB
(2015) Effect of zirconia morphology on hydrogenation of phenol over Pd/ZrO2. ACS Catal 5(12):
7358
14. Docter D, Strieth S, Westmeier D, Hayden O, Gao M, Knauer SK, Stauber RH (2015) No king
without a crown – impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine
(London) 10(3):503–519
15. Driscoll KE (1996) Role of inflammation in the development of rat lung tumors in response to
chronic particle exposure. Inhal Toxicol 8(Suppl):139–153
16. Egerton RF (2011) Electron energy loss in the electron microscope, 3rd ed. Springer, New York
ISBN 978-1-4419-9582-7
17. Elder ACP, Gelein R, Finkelstein JN, Cox C, Oberdörster G (2000) The pulmonary inflamma-tory
response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin.
Inhal Toxicol 12(Suppl. 4):227–246 [PubMed: 12881894]
18. Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdörster G (2005) Effects of
subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and
histopathology. Toxicol Sci 88(2):614–629 [PubMed: 16177241]
19. Elder A, Couderc JP, Gelein R, Eberly S, Cox C, Xia X, Zareba W, Hopke P, Watts W, Kittelson D,
Frampton M, Utell M, Oberdörster G (2007) Effects of on-road highway aerosol exposures on
autonomic responses in aged, spontaneously hypertensive rats. Inhal Toxicol 19:1–12 [PubMed:
17127638]
20. Elder A, Vidyasagar S, DeLouise L (2009) Physicochemical factors that affect metal and metal
oxide nanoparticle passage across epithelial barriers. Wiley Interdiscip Rev Nanomed
Nanobiotechnol 1(4):434–450.4004356 [PubMed: 20049809]
21. Fawcett DW (1966) An atlas of fine structure: the cell, its organelles, and inclusions. W.B.
Saunders, Philidelphia
22. Feynman RP (1960) There’s Plenty of Room at the Bottom. Eng Sci 23(5):22–36
23. Foroozandeh P, Aziz AA (2015) Merging worlds of nanomaterials and biological environment:
factors governing protein corona formation on nanoparticles and its biological consequences.
Nanoscale Res Lett 10:221 4437989 [PubMed: 25995715]
24. Fruijtier-Polloth C (2012) The toxicological mode of action and the safety of synthetic amorphous
silica – A nanostructured material. Toxicology 284(2):61–70. doi:10.1016/j.tox.2012.02.001
25. Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, Peukert W, Treuel L
(2012) Impact of the nanoparticle-protein corona on colloidal stability and protein structure.
Langmuir 28(25):9673–9679 [PubMed: 22524519]
26. Graham UM, Khatri RA, Dozier A, Jacobs G, Davis BH (2009) 3D ridge-valley structure of a Pt
ceria catalyst: HRTEM and EELS spectrum imaging. J Cat Lett 132(2):335–341
27. Graham UM, Tseng MT, Jasinski JB, Yokel RA, Unrine JM, Davis BH, Dozier AK, Hardas SS,
Sultana R, Grulke EA, Butterfield DA (2014) In vivo processing of ceria nanoparticles inside liver:

Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 18

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

impact on free-radical Scavenging activity and oxidative stress. Chempluschem 79(8):1083–
1088.4551665 [PubMed: 26322251]
28. Graham UM, Dozier AK, Wang C, Tseng MT, Fernbeck JE, Birch ME, Davis BH (2015)
Observations of in vivo processing of metal oxide nanoparticles by analytical TEM/STEM.
Microsc Microanal:2287, 21, (Suppl 3)
29. Grosse S, Haugland HK, Lilleng P, Ellison P, Hallan G, Hol PJ (2015) Wear particles and ions from
cemented and uncemented titanium-based hip prostheses-a histological and chemical analysis of
retrieval material. J Biomed Mater Res B Appl Biomater 103(3):709–717. 4413358 [PubMed:
25051953]
30. Gulson B, McCall MJ, Bowman DM, Pinheiro T (2015) A review of critical factors for assessing
the dermal absorption of metal oxide nanoparticles from sunscreens applied to humans, and a
research strategy to address current deficiencies. Arch Toxicol 89(11):1909–1930 [PubMed:
26140917]
31. Hajarul AAW, Nor DZ, Aziz AA, Razak KA (2012) Properties of amorphous silica entrapped
isoniazid drug delivery system. Adv Mat Res 364:134–138
32. Hardas SS, Sultana R, Warrier G, Dan M, Wu P, Grulke EA, Tseng MT, Unrine JM, Graham UM,
Yokel RA, Butterfield DA (2013) Rat hippocampal responses up to 90 days after a single
nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity. Nanotoxicol
8(Suppl. 1):155–166
33. Hartland A, Lead JR, Slaveykova VI, O’Carroll D, Valsami-Jones E (2013) The environmental
significance of natural nanoparticles. Nat Educ Knowl 4(8):7
34. Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, Levsen K (1995)
Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine
exhaust, carbon black, and titanium dioxide. Inhal Toxicol 7:533–556
35. Hellmann R, Cotte S, Cadel E, Malladi S, Karlsson LS, Lozano-Perez S, Cabie M, Seyeux A
(2015) Nanometre-scale evidence for interfacial dissolution-reprecipitation control of silicate glass
corrosion. Nat Mater 14(3):307–311 [PubMed: 25559424]
36. Hirsch PB, Howie A, Whelan MJ (1962) On the production of X-rays in thin metal foils. Philos
Mag 7:2095–2100
37. Hodgson KO, Hedman B, Penner-Hahn JE (eds) (1984) EXAFS and near edge structure III, Proc
In Physics 2, Springer, Berlin/Heidelberg GmbH
38. Honarmand Ebrahimi K, Bill E, Hagedoorn PL, Hagen WR (2012) The catalytic center of ferritin
regulates iron storage via Fe(II)-Fe(III) displacement. Nat Chem Biol 8(11):941–948. doi:10.1038/
nchembio.1071 [PubMed: 23001032]
39. Jones JR (2013) Review of bioactive glass: from Hench to hybrids. Acta Biomater 9(1):4457–4486
[PubMed: 22922331]
40. Keller J, Wohlleben W, Ma-Hock L, Strauss V, Gröters S, Küttler K, Wiench K, Herden C,
Oberdörster G, Van Ravenzwaay B, Landsiedel R (2014) Time course of lung retention and
toxicity of inhaled particles: short-term exposure to nano-ceria. Arch Toxicol 88(11): 2033–2059
[PubMed: 25273020]
41. Kim CK, Kim T, Choi IY, Soh M, Kim D, Kim YJ, Jang H, Yang HS, Kim JY, Park HK, Park S,
Yu T, Yoon BW, Lee SH, Hyeon T (2012) Ceria nanoparticles that can protect against ischemic
stroke. Angew Chem Int Ed Eng 51:11039
42. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S,
Oberdörster G (2009) Size dependence of the translocation of inhaled iridium and carbon
nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal
Toxicol 21(Suppl. 1):55–60
43. Krug HF (2014) Nanosafety research – are we on the right track. J Angew Chemie 53(46):12304–
12319
44. Lemire JA, Harrison JJ, Turner RJ (2013) Box 3: the Fenton reaction, free radical chemistry and
metal poisoning. Nat Rev Microbiol 11:371–384. doi:10.1038/nrmicro3028 [PubMed: 23669886]
45. Linganiso L, Pendyala V, Jacobs G, Davis B, Cronauer D, Kropf A, Marshall C (2011) Lowtemperature water-gas-shift: doping ceria improves reducibility and mobility of O-bound species
and catalyst activity. Cat Letters 141(12):1723

Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 19

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

46. Loane RF, Kirkland EJ, Silcox J (1988) Visibility of single heavy atoms on thin cyrstalline silicon
in simulated annular dark-field STEM images. Acta Crystallogr A 44:912–927
47. Mai HX, Sun LD, Zhang YW, Si R, Feng W, Zhang HP, Liu HC, Yan CH (2005) Shape- selective
synthesis of oxygen storage behavior of ceria nanopolyhedra, nanorods and naocubes. J Phys
Chem B 109(51):24380–24385. doi:10.1021/jp055584b [PubMed: 16375438]
48. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V (2004) Exposure to
carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon
nanotube material. J Toxicol Environ Health Part A 67(1):87–107 [PubMed: 14668113]
49. Massie I, Dziasko M, Kureshi A, Levis HJ, Morgan L, Neale M, Sheth R, Tovell VE, Vernon AJ,
Funderburgh JL, Daniels JT (2015) Advanced imaging and tissue engineering of the human limbal
epithelial stem cell niche. Methods Mol Biol 1235:179–202. doi:10.1007/978-1-4939-1785-3_15
[PubMed: 25388395]
50. Mercer RR, Scabilloni JF, Hubbs AF, Wang L, Battelli LA, McKinney W, Castranova V, Porter
DW (2013) Extrapulmonary transport of MWCNT following inhalation exposure. Part Fibre
Toxicol 10(38):13 [PubMed: 23587247]
51. Mortensen LJ, Ravichandran S, Delouise LA (2013) The impact of UVB exposure and
differentiation state of primary keratinocytes on their interaction with quantum dots.
Nanotoxicology 7:1244–1254 3779483 [PubMed: 22998293]
52. Mortensen LJ, Faulknor R, Ravichandran S, Zheng H, DeLouise LA (2015) UVB dependence of
quantum dot reactive oxygen species generation in common skin cell models. J Biomed
Nanotechnol 11(9):1644–1652 PMCID: PMC4625909 [PubMed: 26485933]
53. Muller DA, Sorsch T, Moccio S, Baumann FH, Evans-Lutterodt K, Timp G (1999) The electronic
structure at the atomic scale of ultrathin gate oxides. Nature 399:758–761
54. Naess EM, Hofgaard A, Skaug V, Gulbrandsen M, Danielsen TE, Grahnstedt S, Skogstad A, Holm
JO (2015) Titanium dioxide nanoparticles in sunscreen penetrate the skin into viable layers of the
epidermis: a clinical approach. Photodermatol Photoimmunol Photomed 32(1):48–51 [PubMed:
26447850]
55. Nagashima K, Zheng J, Pamiter D, Patri AK (2011) Biological tissue and cell culture specimen
preparation for TEM nanoparticle characterization. Methods Mol Biol 697:83–91. doi:
10.1007/978-1-60327-198-1_8 [PubMed: 21116956]
56. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science
311:622–627 [PubMed: 16456071]
57. Nellist PD, Pennycook SJ (2000) The principles and interpretation of annular dark-field Z contrast
imaging. Advances Imaging Electron Phys 113:147–203
58. Oberdörster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder ACP (2000) Acute
pulmonary effects of ultrafine particles in rats and mice. Health Effects Institute, Cambridge, pp.
1–74
59. Oberdörster G (2002) Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol
14:29–56 [PubMed: 12122559]
60. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation
of inhaled ultrafine particles to the brain. Inhal Toxicol 16(6–7):437–445 [PubMed: 15204759]
61. Oberdörster G, Oberdörster E, Oberdörster J (2007) Concepts of nanoparticle dose metric and
response metric. Environ Health Perspect 115(6):A290 PMC1892118
62. Oberdörster G (2015) Predictive modeling of nanomaterial risk: combining or replacing in vivo
with in vitro studies? CompNanoTox, 4 Nov, Malaga, Spain
63. Pan Y-H, Sader K, Powell JJ, Bleloch A, Gass M, Trinick J, Warley A, Brydson AR, Brown A
(2009) 3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit
structure revealed by single particle analysis of HAADF-STEM images. J Struct Biol 166(1):22–
31. doi:10.1016/j.jsb.2008.12.001 [PubMed: 19116170]
64. Pan H, Myerson JW, HU L, Marsh JN, Hou K, Scott MJ, Allen JS, Hu G, Roman SS, Lanza GM,
Schreiber RD, Schlesinger PH, Wickline SA (2013) Programmable nanoparticle functionalization
for in vivo targeting. FASEB 27(1):255–264
65. Pennycook SJ, Varela M (2011) New views of materials through aberration-corrected scanniung
transmission electron microscopy. Microscopy 60(1):5213–5223

Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 20

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

66. Ravichandran S, Mortensen LJ, DeLouise LA (2011) Quantification of human skin barrier function
and susceptibility to quantum dot skin penetration. Nanotoxicol 5(4):675–686 PMID: 21142716
67. Rehr JJ, Kas JJ, Vila FD, Prange MP, Jorissen K (2010) Parameter-free calculations of X-ray
spectra with FEFF9. Phys Chem Chem Phys 12(21):5503–5513. doi:10.1039/b926434e [PubMed:
20445945]
68. Ribeiro MC, Jacobs G, Davis BH, Cronauer DC, Kropf AJ, Marshall CL (2010) Fischer- Tropsch
synthesis: deactivation as a function of potassium promoter loading for precipitated iron catalyst. J
Phys Chem C 114:7895–7903
69. Rushton EK, Jiang J, Leonard SS, Eberly S, Castranova V, Biswas P, Elder A, Han X, Gelein R,
Finkelstein J, Oberdorster G (2010) Concept of assessing nanoparticle hazards considering
nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A
73(5):445–461 [PubMed: 20155585]
70. Sader K, Pan Y, Bleloch AL, Brydson R, Brown A (2008) Structural characterization of proteincaged iron minerals in biological systems. J. Physics: Conference Series 126(2008) 012006. doi:
10.1088/1742-6596/126/1/012006
71. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG (2004) Long- term
clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including
transient translocation into secondary organs. Inhal Toxicol 16:453–459 [PubMed: 15204761]
72. Sotiriou GA, Watson C, Murdaugh KM, Darrah TH, Pyrgiotakis G, Elder A, Brain JD, Demokritou
P (2014) Engineering safer-by-design silica-coated ZnO nanorods with reduced DNA damage
potential. Environ Sci Nano 1(2):144–153 PMC4060637 [PubMed: 24955241]
73. Surekha P, Kishore AS, Srinivas A, Selvam G, Goparaju A, Reddy PN, Murthy PB (2012)
Repeated dose dermal toxicity study of nano zinc oxide with Sprague-Dawley rats. Cutan Ocul
Toxicol 31(1):26–32 [PubMed: 21830917]
74. Tomer R, Ye L, Hsueh B, Deisseroth k (2014) Advanced clarity for rapid and high-resolution
imaging of intact tissues. Nat Protoc 9:1682–1697. doi:10.1038/nprot.2014.123 [PubMed:
24945384]
75. Tosha T, Behera RK, Ng HL, Bhattasali O, Alber T, Theil EC (2012) Ferritin protein nanocage ion
channels: gating by N-terminal extensions. J Biol Chem 287(16):13016–13025. doi:10.1074/
jbc.M111.332734 [PubMed: 22362775]
76. Toumey C (2009) Plenty of room, plenty of history. Nat Nanotechnol 4:783–784 [PubMed:
19966818]
77. Turner S, Lazar S, Freitag B, Egoavil R, Verbeeck J, Put S, Strauven Y, VanTendeloo G (2011)
High resolution mapping of surface reduction in ceria nanoparticles. Nanoscale 3(8):3385–3390.
doi:10.1039/c1nr10510h [PubMed: 21720618]
78. Utembe W, Potgieter K, Stefaniak AB, Gulumian M (2015) Dissolution and biodurability:
important parameters needed for risk assessment of nanomaterials. Part. Fibre Toxicol 12(11):12
[PubMed: 25944145]
79. Walkey CD, Chan WC (2012) Understanding and controlling the interaction of nanomaterials with
proteins in a physiological environment. Chem Soc Rev 41(7):2780–2799 [PubMed: 22086677]
80. Wang W, McCool G, Kapur N, Yuan G, Shan B, Nguyen M, Graham UM, Davis BH, Jacobs G,
Cho K, Hao X (2012) Mixed-phase oxide catalyst based on Mn-mullite (Sm, Gd)Mn2O5 for NO
oxidation in diesel exhaust. Science 337(6096):832–835 [PubMed: 22904009]
81. Williams DB, Carter CB (2009) ISBN-10: 0387765026 Transmission electron microscopy a
textbook for materials science, 2nd edn Springer, New York
82. Wong J, Lytle FW, Greegor RB, Maylotte DH, Lamson S, Glover B (1984) EXAFS and XANES
studies of trace elements in coal, in EXAFS and Near Edge Structure III, Proc. in Physics 2.
Hodgson KO, Hedman B, Penner-Hahn JE (eds), Springer Berlin, Heidelberg GmbH 1984, p 362–
367
83. Wu J, Liu W, Xue C, Zhou S, Lan F, Bi L, Xu H, Yang X, Zeng FD (2009) Toxicity and
penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal
exposure. Toxicol Lett 191(1):1–8 [PubMed: 19501137]

Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 21

Author Manuscript
Author Manuscript

84. Wu JS, Kim AM (2013) Imaging and elemental mapping of biological speciments with a dualEDS dedicated scanning transmission electron microscope. Ultramicroscopy 128:24–31 [PubMed:
23500508]
85. Wu N, Xie Y, Nel A, Holian A (2013) Inter-laboratory comparison of in vitro nanotoxicological
assays from the NIEHS NanoGo Consortium. Environ Health Perspect 121:683–690 PMC3672931
[PubMed: 23649538]
86. Yang H, Lozano JG, Pennycook SJ, Jones L, Hirsch PB, Nellist PD (2015) Imaging screw
dislocations at atomic resolution by aberration-corrected electron optical sectioning. Nat Comm
6:7266. doi:10.1038/ncomms8266
87. Yokel RA, Au TC, MacPhail RC, Hardas SS, Butterfield DA, Sultana R, Goodman M, Tseng MT,
Dan M, Haghnazar SS, Unrine JM, Graham UM (2012) Distribution, elimination, and
biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in
rats. Toxicol Sci 127(1):256–268 [PubMed: 22367688]
88. Zhang H, Ji Z, Xia T, Meng H, Low-Kam C, Liu R, Pokhrel S, Lin S, Wang X, Liao YP, Wang M,
Li L, Rallo R, Damoiseaux R, Telesca D, Mädler L, Cohen Y, Zink JI, Nel AE (2012) Use of metal
oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute
pulmonary inflammation. ACS Nano 6(5):4349–4368 [PubMed: 22502734]

Author Manuscript
Author Manuscript
Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 22

Author Manuscript
Fig. 4.1.

Schematic illustration of nanoparticle dose-dependent reactivity and physiological response
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Fig. 4.2.

From dose to response: MNPs characterization, followed by dose-dependent exposure in
rodent model, uptake into organs/tissues, in vivo processing and nanotoxicity assessment
and modelling
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Fig. 4.3.

Nanoparticle breakdown can lead to improved biocompatibility
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Fig. 4.4.

illustrates precursor SiO2-MNPs prior to dose controlled inhalation into lungs. (a) Large
agglomerates. (b) Precursor SiO2-MNPs with amorphous nanostructures and predominantly
spherical shape. Some overlapping spheres are marked with circles
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Fig. 4.5.

Author Manuscript

Dark field STEM imaging of lung section after repeated dose inhalation and 27 days post
treatment. SiO2-MNPs show pores and significant in vivo processing. Almost all of the
original spherical morphology has disappeared after 27 days post treatment exposure. SiO2MNPs show dissolution patterns, void/pore formation (yellow arrows) and significant
outward growth of reaction zones (secondary growth shown by blue arrow)
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Fig. 4.6.
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Elemental EDS maps of O, Si, S, and P taken from a region in Fig. 4.4
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Fig. 4.7.

Dark Field STEM imaging and EDS spot analyses show the bioprocessing of SiO2-MNPs in
alveolar macrophages. Migration of Si occurred outwards and led to a secondary reaction
zone “Si-cloud” between SiO2-MNPs and yellow line. The small very bright spots in the Sicloud region are ferritin nanoparticles
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Fig. 4.8.

(a) Dark Field STEM image shows in vivo breakdown of SiO2-MNPs in alveolar
macrophage (Zone I) and formation of Zone II. (b) Magnified region shows small
nanoparticles in Zone II

Author Manuscript
Author Manuscript
Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 30

Author Manuscript
Author Manuscript

Fig. 4.9.

STEM and EELS analyses of CeO2-MNPs in spleen after a therapeutic dose and 14 days
residence time. Analysis of the ceria M5/M4 ratio along the line profile from an EELS
spectrum image
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Fig. 4.10.

Schematic illustration of energy loss for computing EELS edges for Ce

Author Manuscript
Author Manuscript
Adv Exp Med Biol. Author manuscript; available in PMC 2019 February 15.

Graham et al.

Page 32

Author Manuscript
Author Manuscript
Fig. 4.11.

TEM and HRTEM images with increasing magnification show the presence of CeO2-MNPs
and Ce-phosphate after in vivo processing and leads to a local arrangement. Many MNPs are
self- aligning to form needle- shaped structures indicted with red arrows
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Fig. 4.12.

CeO2-MNPs are imaged using low angle dark field STEM condition showing cellular
structures in the spleen. The CeO2-MNPs localize around cellular inclusions
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Fig. 4.13.
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STEM spectrum imaging and elemental maps of Ce-MNPs localized around spleen
inclusions
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Fig. 4.14.
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SiO2-MNPs in TEM and dark field STEM showing cellular structure of the alveolar
macrophage, location. The SiO2-MNPs are surrounded by ferritin nanoparticle halos
identified using EELS spot analysis
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Fig. 4.15.

CeO2-MNPs in dark field STEM showing cellular structure in the spleen macrophage. The
CeO2-MNPs localize around cellular inclusions and are surrounded by ferritin nanoparticles
identified using EELS spot analysis
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Fig. 4.16.
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(a) XANES spectra for iron oxide; (b) EXAFS recorded during heating
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Fig. 4.17.

(a) XANES for Ce+3 and Ce+4 and (b) XANES as a function of heating
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